Although (podocyte-derived) VEGF is usually considered to mediate the development of diabetic nephropathy [14], it has also been described that VEGF can be protective in diabetic nephropathy [15], providing a possible explanation for ‘better’ normalisation after SPK in patients with an MBL polymorphism. Here, MBL2 is linked to diabetic kidney disease.